Found: 26
Select item for more details and to access through your institution.
Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 1, p. 107, doi. 10.1002/cpdd.685
- By:
- Publication type:
- Article
Assessment of Bezlotoxumab Immunogenicity.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 3, p. 330, doi. 10.1002/cpdd.729
- By:
- Publication type:
- Article
PBPK-PD modeling for the preclinical development and clinical translation of tau antibodies for Alzheimer's disease.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.867457
- By:
- Publication type:
- Article
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man.
- Published in:
- Scientific Reports, 2016, p. 27147, doi. 10.1038/srep27147
- By:
- Publication type:
- Article
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold.
- Published in:
- BMC Neuroscience, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2202-14-90
- By:
- Publication type:
- Article
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00538-1
- By:
- Publication type:
- Article
Pharmacokinetics, safety and tolerability of long‐acting parenteral intramuscular injection formulations of doravirine.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2020, v. 45, n. 5, p. 1098, doi. 10.1111/jcpt.13182
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug–Drug Interactions.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 10, p. 927, doi. 10.1007/s40261-020-00934-2
- By:
- Publication type:
- Article
Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2019, v. 39, n. 5, p. 441, doi. 10.1007/s40261-019-00764-x
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 7, p. 631, doi. 10.1007/s40261-018-0650-4
- By:
- Publication type:
- Article
Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof‐of‐Concept Application of Liquid Biopsy in Renal Impairment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 3, p. 814, doi. 10.1002/cpt.3291
- By:
- Publication type:
- Article
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 3, p. 615, doi. 10.1002/cpt.2672
- By:
- Publication type:
- Article
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 2, p. 508, doi. 10.1002/cpt.2277
- By:
- Publication type:
- Article
A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 403, doi. 10.1002/cpt.1998
- By:
- Publication type:
- Article
A time-to-event analysis of the exposure–response relationship for bezlotoxumab concentrations and CDI recurrence.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2020, v. 47, n. 2, p. 121, doi. 10.1007/s10928-019-09660-5
- By:
- Publication type:
- Article
Erratum to: A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate.
- Published in:
- AAPS PharmSciTech, 2020, v. 21, n. 3, p. 1, doi. 10.1208/s12249-020-1630-6
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 3, p. 394, doi. 10.1002/jcph.1747
- By:
- Publication type:
- Article
A Study to Evaluate Doravirine Pharmacokinetics When Coadministered With Acid‐Reducing Agents.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 8, p. 1093, doi. 10.1002/jcph.1399
- By:
- Publication type:
- Article
Multiple Doses of Rifabutin Reduce Exposure of Doravirine in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 8, p. 1044, doi. 10.1002/jcph.1103
- By:
- Publication type:
- Article
Evaluation of Model‐Based Prediction of Pharmacokinetics in the Renal Impairment Population.
- Published in:
- Journal of Clinical Pharmacology, 2018, v. 58, n. 3, p. 364, doi. 10.1002/jcph.1022
- By:
- Publication type:
- Article
Moderate Hepatic Impairment Does Not Affect Doravirine Pharmacokinetics.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 6, p. 777, doi. 10.1002/jcph.857
- By:
- Publication type:
- Article
Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects.
- Published in:
- 2015
- By:
- Publication type:
- journal article